Kangstem Biotech Co. Ltd (217730) - Total Liabilities

Latest as of March 2026: ₩12.20 Billion KRW ≈ $8.27 Million USD

Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has total liabilities worth ₩12.20 Billion KRW (≈ $8.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Kangstem Biotech Co. Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Kangstem Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Kangstem Biotech Co. Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Kangstem Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Boa Safra Sementes S.A SA:SOJA3	Brazil	R$2.11 Billion
Tung Thih Electronic Co Ltd TWO:3552	Taiwan	NT$6.26 Billion
Circus SE XETRA:CA1	Germany	€16.62 Million
Epsilon Energy Ltd NASDAQ:EPSN	USA	$102.30 Million
Dollar Industries Limited NSE:DOLLAR	India	Rs5.90 Billion
Seoul Broadcasting System KO:034120	Korea	₩686.54 Billion
Li Peng Enterprise Co Ltd TW:1447	Taiwan	NT$7.65 Billion
Freightcar America Inc NASDAQ:RAIL	USA	$353.28 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Kangstem Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 217730 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.20	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kangstem Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kangstem Biotech Co. Ltd (2015–2025)

The table below shows the annual total liabilities of Kangstem Biotech Co. Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩12.43 Billion ≈ $8.43 Million	-2.90%
2024-12-31	₩12.80 Billion ≈ $8.68 Million	-65.15%
2023-12-31	₩36.74 Billion ≈ $24.90 Million	+10.21%
2022-12-31	₩33.33 Billion ≈ $22.59 Million	-4.97%
2021-12-31	₩35.07 Billion ≈ $23.77 Million	+13.56%
2020-12-31	₩30.89 Billion ≈ $20.93 Million	-28.04%
2019-12-31	₩42.92 Billion ≈ $29.09 Million	+68.30%
2018-12-31	₩25.50 Billion ≈ $17.28 Million	+13.65%
2017-12-31	₩22.44 Billion ≈ $15.21 Million	-8.27%
2016-12-31	₩24.46 Billion ≈ $16.58 Million	+553.16%
2015-12-31	₩3.75 Billion ≈ $2.54 Million	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$160.30 Million

₩236.55 Billion KRW

Market Cap Rank

#17487 Global

#720 in Korea

Share Price

₩2515.00

Change (1 day)

-6.85%

52-Week Range

₩1171.00 - ₩4615.00

All Time High

₩18836.30